ASXL1 mutations are associated with disorders such as Bohring–Opitz syndrome (BOS), acute myeloid leukemia (AML), and embryonic developmental defects [10,11,12,13,14]. This evidence concerns the gene ASXL1 and acute myeloid leukemia.